<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940217-2-00070</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>National Institutes of Health</USBUREAU> <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 -->  <DOCTITLE>Office of the Director; Meetings of the Women's Health Initiative Program Advisory Committee and Its Subcommittees</DOCTITLE> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Pursuant to Public Law 92&hyph;463, notice is hereby given of the meeting of the Women's Health Initiative Program Advisory Committee (WHIPAC), Office of the Director, and its subcommittees, on February 28 and March 1, 1994. All meetings will be held at the ANA Hotel, 2401 M Street, NW., Washington, DC 20037 and will be open to the public, with attendance limited to space available. Notice of the meeting rooms will be posted in the hotel lobby. <!-- PJG 0012 frnewline --> The meeting of the full committee will be on March 1, 1994, from 8 a.m. to 4 p.m. The purpose of the meeting is to review the status and progress in the planning and conduct of the Women's Health Initiative (WHI), and to advise the NIH Director on the comprehensive plan of prevention studies in the WHI. There will also be a panel discussion on hormone replacement therapy. <!-- PJG 0012 frnewline --> The WHIPAC subcommittee meetings (Recruitment and Retention, Public Education, and Study Management) will be held on February 28, 1994 from 7 p.m. to 8:30 p.m. for the discussion of issues pertaining to the recruitment of study subjects to the clinical trial, the informed consent process, center activities, and the dissemination of information to the public. <!-- PJG 0012 frnewline --> Dr. Carrie P. Hunter, Special Assistant to the Director, Office of Research on Women's Health, National Institutes of Health, Bethesda, Maryland 20892 (301&hyph;402&hyph;2900) will provide a summary of the meeting, a roster of committee members, and substantive program information, upon request. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should contact Ms. Dina Battle of Conwal Incorporated, at 703&hyph;536&hyph;3200 in advance of the meeting. <!-- PJG 0012 frnewline --> This notice is being published less than 15 days before the meeting due to the difficulty of coordinating conflicting schedules. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: February 14, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Susan K. Feldman, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Committee Management Officer, NIH. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;3732 Filed 2&hyph;16&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4140&hyph;01&hyph;M <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            